Your browser doesn't support javascript.
loading
Replacing vaccine paper package inserts: a multi-country questionnaire study on the acceptability of an electronic replacement in different target groups.
Bamberger, Martina; De Loof, Hans; Marstboom, Charlotte; Oury, Stéphanie; Bonanni, Paolo; Launay, Odile; Kojouharova, Mira; Van Damme, Pierre.
Afiliação
  • Bamberger M; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium. Martina.Bamberger@uantwerpen.be.
  • De Loof H; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
  • Marstboom C; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
  • Oury S; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
  • Bonanni P; Department of Health Sciences, University of Florence, Florence, Italy.
  • Launay O; CIC Cochin Pasteur, Paris, France.
  • Kojouharova M; Epidemiology consultant, Sofia, Bulgaria.
  • Van Damme P; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
BMC Public Health ; 22(1): 156, 2022 01 24.
Article em En | MEDLINE | ID: mdl-35073891
ABSTRACT

BACKGROUND:

In the European Union it is mandatory to include paper package leaflets (PPL) with all medicines, including vaccines, to inform the recipient. However, it is difficult to meet the necessity for localized PPLs in each of the 24 official European languages. Replacing PPLs with electronic versions offers many advantages including redistribution across nations, reduced storage space, accessibility by the visually impaired, easily updated information or the addition of video content. We wanted to assess the attitudes of patients (vaccine recipients or their parents) to the potential of replacing PPL with electronic versions.

METHODS:

We surveyed vaccinees or their parents in four European countries-Belgium, Italy, Bulgaria and France-for their actual use of vaccine PPLs and their opinions about switching to an electronic package leaflet. Our survey was conducted online because of the COVID-19 pandemic and resulted in 2518 responses to a questionnaire targeted at three specific groups with particular information needs parents of young children, pregnant women and the elderly (≥ 60 years).

RESULTS:

Our main findings are that currently vaccine PPLs are rarely used and frequently unavailable for the vaccinee. Across the four countries surveyed 55-82% of vaccinees would accept an electronic version, as did 64% when there was an option to request a printout of the leaflet.

CONCLUSIONS:

We found that switching to electronic versions of vaccine PPLs is an acceptable alternative for the public, potentially increasing the quality and amount of information reaching vaccinees while eliminating some barriers to redistribution of vaccines between countries.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Aged / Child / Child, preschool / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Aged / Child / Child, preschool / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article